

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.27967676 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.27967676 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.19999588 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.19999588 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.56870680 |
| 6 | glyoxylate metabolic process (GO:0046487) | 5.14593869 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.14297742 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.08373851 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.08373851 |
| 10 | tryptophan catabolic process (GO:0006569) | 5.08373851 |
| 11 | sulfur amino acid catabolic process (GO:0000098) | 5.07628191 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.03194161 |
| 13 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.95431979 |
| 14 | cysteine metabolic process (GO:0006534) | 4.89580346 |
| 15 | bile acid biosynthetic process (GO:0006699) | 4.89079551 |
| 16 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.86665415 |
| 17 | tryptophan metabolic process (GO:0006568) | 4.85175939 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 4.78266134 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.54362998 |
| 20 | positive regulation of B cell differentiation (GO:0045579) | 4.54089773 |
| 21 | lysine catabolic process (GO:0006554) | 4.53577451 |
| 22 | lysine metabolic process (GO:0006553) | 4.53577451 |
| 23 | urea metabolic process (GO:0019627) | 4.53576207 |
| 24 | urea cycle (GO:0000050) | 4.53576207 |
| 25 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.52802107 |
| 26 | high-density lipoprotein particle remodeling (GO:0034375) | 4.45025571 |
| 27 | amino-acid betaine metabolic process (GO:0006577) | 4.41343994 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.38944573 |
| 29 | protein carboxylation (GO:0018214) | 4.38944573 |
| 30 | complement activation, alternative pathway (GO:0006957) | 4.37765133 |
| 31 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.36963984 |
| 32 | negative regulation of fibrinolysis (GO:0051918) | 4.35124367 |
| 33 | response to pheromone (GO:0019236) | 4.29873420 |
| 34 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.27789823 |
| 35 | regulation of protein activation cascade (GO:2000257) | 4.22165288 |
| 36 | regulation of triglyceride catabolic process (GO:0010896) | 4.19382166 |
| 37 | regulation of cholesterol esterification (GO:0010872) | 4.18778550 |
| 38 | nitrogen cycle metabolic process (GO:0071941) | 4.16485737 |
| 39 | ethanol oxidation (GO:0006069) | 4.15543816 |
| 40 | aromatic amino acid family metabolic process (GO:0009072) | 4.13398196 |
| 41 | serine family amino acid catabolic process (GO:0009071) | 4.10248297 |
| 42 | tyrosine metabolic process (GO:0006570) | 4.09974720 |
| 43 | regulation of fibrinolysis (GO:0051917) | 4.08440642 |
| 44 | bile acid metabolic process (GO:0008206) | 4.04330591 |
| 45 | imidazole-containing compound metabolic process (GO:0052803) | 3.99976934 |
| 46 | phospholipid efflux (GO:0033700) | 3.97679975 |
| 47 | regulation of complement activation (GO:0030449) | 3.96617789 |
| 48 | coenzyme catabolic process (GO:0009109) | 3.95980290 |
| 49 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.91123499 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 3.85711285 |
| 51 | sperm capacitation (GO:0048240) | 3.84920007 |
| 52 | reverse cholesterol transport (GO:0043691) | 3.78712218 |
| 53 | cofactor catabolic process (GO:0051187) | 3.77183758 |
| 54 | protein-lipid complex remodeling (GO:0034368) | 3.74700840 |
| 55 | macromolecular complex remodeling (GO:0034367) | 3.74700840 |
| 56 | plasma lipoprotein particle remodeling (GO:0034369) | 3.74700840 |
| 57 | carnitine metabolic process (GO:0009437) | 3.74329688 |
| 58 | NAD biosynthetic process (GO:0009435) | 3.73793863 |
| 59 | homocysteine metabolic process (GO:0050667) | 3.73174606 |
| 60 | sperm motility (GO:0030317) | 3.72800270 |
| 61 | glycine metabolic process (GO:0006544) | 3.72412809 |
| 62 | acylglycerol homeostasis (GO:0055090) | 3.72389485 |
| 63 | triglyceride homeostasis (GO:0070328) | 3.72389485 |
| 64 | negative regulation of sterol transport (GO:0032372) | 3.69126625 |
| 65 | negative regulation of cholesterol transport (GO:0032375) | 3.69126625 |
| 66 | ribosomal small subunit assembly (GO:0000028) | 3.66824474 |
| 67 | cellular modified amino acid catabolic process (GO:0042219) | 3.65943889 |
| 68 | serine family amino acid metabolic process (GO:0009069) | 3.65694193 |
| 69 | positive regulation of granulocyte differentiation (GO:0030854) | 3.65527927 |
| 70 | plasma lipoprotein particle clearance (GO:0034381) | 3.64817367 |
| 71 | negative thymic T cell selection (GO:0045060) | 3.64197453 |
| 72 | indolalkylamine metabolic process (GO:0006586) | 3.62851065 |
| 73 | cellular amino acid catabolic process (GO:0009063) | 3.61948757 |
| 74 | cellular biogenic amine catabolic process (GO:0042402) | 3.61777372 |
| 75 | amine catabolic process (GO:0009310) | 3.61777372 |
| 76 | negative regulation of granulocyte differentiation (GO:0030853) | 3.60714855 |
| 77 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.59371469 |
| 78 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.59371469 |
| 79 | benzene-containing compound metabolic process (GO:0042537) | 3.59326829 |
| 80 | 2-oxoglutarate metabolic process (GO:0006103) | 3.56398890 |
| 81 | valine metabolic process (GO:0006573) | 3.55945618 |
| 82 | aldehyde catabolic process (GO:0046185) | 3.54489541 |
| 83 | fatty acid beta-oxidation (GO:0006635) | 3.54063838 |
| 84 | negative regulation of cell killing (GO:0031342) | 3.53994316 |
| 85 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.53994316 |
| 86 | negative T cell selection (GO:0043383) | 3.51243954 |
| 87 | regulation of gamma-delta T cell activation (GO:0046643) | 3.51150811 |
| 88 | blood coagulation, intrinsic pathway (GO:0007597) | 3.50886074 |
| 89 | cellular glucuronidation (GO:0052695) | 3.47871958 |
| 90 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.46649541 |
| 91 | serine family amino acid biosynthetic process (GO:0009070) | 3.44360469 |
| 92 | regulation of granulocyte differentiation (GO:0030852) | 3.43817119 |
| 93 | fatty acid oxidation (GO:0019395) | 3.43337726 |
| 94 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.42005273 |
| 95 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.41550314 |
| 96 | bile acid and bile salt transport (GO:0015721) | 3.40048106 |
| 97 | carboxylic acid catabolic process (GO:0046395) | 3.38641651 |
| 98 | organic acid catabolic process (GO:0016054) | 3.38641651 |
| 99 | definitive hemopoiesis (GO:0060216) | 3.37934382 |
| 100 | response to nitrosative stress (GO:0051409) | 3.36359711 |
| 101 | lipid oxidation (GO:0034440) | 3.36146471 |
| 102 | primary alcohol catabolic process (GO:0034310) | 3.35095330 |
| 103 | cellular ketone body metabolic process (GO:0046950) | 3.34251300 |
| 104 | opsonization (GO:0008228) | 3.33619874 |
| 105 | thymic T cell selection (GO:0045061) | 3.32486901 |
| 106 | monocarboxylic acid catabolic process (GO:0072329) | 3.31885925 |
| 107 | fatty acid catabolic process (GO:0009062) | 3.31664046 |
| 108 | drug transmembrane transport (GO:0006855) | 3.30818843 |
| 109 | plasma lipoprotein particle assembly (GO:0034377) | 3.28625863 |
| 110 | arginine metabolic process (GO:0006525) | 3.27555608 |
| 111 | xenobiotic catabolic process (GO:0042178) | 3.26666258 |
| 112 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.26166162 |
| 113 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.26166162 |
| 114 | acetyl-CoA metabolic process (GO:0006084) | 3.25545953 |
| 115 | mast cell degranulation (GO:0043303) | 3.24699234 |
| 116 | mast cell activation involved in immune response (GO:0002279) | 3.24699234 |
| 117 | glutamate metabolic process (GO:0006536) | 3.24576547 |
| 118 | cholesterol efflux (GO:0033344) | 3.24283312 |
| 119 | acrosome reaction (GO:0007340) | 3.23772718 |
| 120 | positive thymic T cell selection (GO:0045059) | 3.23479649 |
| 121 | regulation of B cell differentiation (GO:0045577) | 3.23234177 |
| 122 | regulation of cholesterol homeostasis (GO:2000188) | 3.23220341 |
| 123 | negative regulation of lipase activity (GO:0060192) | 3.21729032 |
| 124 | ethanol metabolic process (GO:0006067) | 3.21320354 |
| 125 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 3.21086967 |
| 126 | aspartate family amino acid catabolic process (GO:0009068) | 3.20897382 |
| 127 | low-density lipoprotein particle remodeling (GO:0034374) | 3.20708593 |
| 128 | regulation of cholesterol metabolic process (GO:0090181) | 3.20639844 |
| 129 | viral transcription (GO:0019083) | 3.19510423 |
| 130 | short-chain fatty acid metabolic process (GO:0046459) | 3.18851496 |
| 131 | positive regulation of lipid catabolic process (GO:0050996) | 3.17371471 |
| 132 | mature B cell differentiation involved in immune response (GO:0002313) | 3.16318131 |
| 133 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 3.08366693 |
| 134 | ribosomal small subunit biogenesis (GO:0042274) | 2.98818957 |
| 135 | mast cell activation (GO:0045576) | 2.96157211 |
| 136 | regulation of mast cell degranulation (GO:0043304) | 2.94200455 |
| 137 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.92682799 |
| 138 | rRNA modification (GO:0000154) | 2.92288566 |
| 139 | chromosome condensation (GO:0030261) | 2.91657758 |
| 140 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.91374252 |
| 141 | rRNA methylation (GO:0031167) | 2.90205668 |
| 142 | negative regulation of B cell apoptotic process (GO:0002903) | 2.89816709 |
| 143 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.89651942 |
| 144 | cell wall macromolecule metabolic process (GO:0044036) | 2.89465487 |
| 145 | translational termination (GO:0006415) | 2.88638978 |
| 146 | megakaryocyte development (GO:0035855) | 2.88458002 |
| 147 | microtubule severing (GO:0051013) | 2.87108352 |
| 148 | DNA packaging (GO:0006323) | 2.86927567 |
| 149 | response to peptidoglycan (GO:0032494) | 2.86651248 |
| 150 | UV protection (GO:0009650) | 2.84813883 |
| 151 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.84653870 |
| 152 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.84189497 |
| 153 | pentose metabolic process (GO:0019321) | 2.81560033 |
| 154 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.78972076 |
| 155 | translational elongation (GO:0006414) | 2.78033878 |
| 156 | pinocytosis (GO:0006907) | 2.77125778 |
| 157 | plasma membrane fusion (GO:0045026) | 2.76964673 |
| 158 | immunoglobulin mediated immune response (GO:0016064) | 2.76500808 |
| 159 | leukocyte degranulation (GO:0043299) | 2.76339858 |
| 160 | sleep (GO:0030431) | 2.76118553 |
| 161 | response to interferon-beta (GO:0035456) | 2.75904329 |
| 162 | protein-DNA complex disassembly (GO:0032986) | 2.75086362 |
| 163 | nucleosome disassembly (GO:0006337) | 2.75086362 |
| 164 | actin nucleation (GO:0045010) | 2.75008128 |
| 165 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.74770131 |
| 166 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.72714772 |
| 167 | tolerance induction (GO:0002507) | 2.72500101 |
| 168 | homeostasis of number of cells within a tissue (GO:0048873) | 2.71855335 |
| 169 | response to muramyl dipeptide (GO:0032495) | 2.69288103 |
| 170 | deoxyribonucleotide catabolic process (GO:0009264) | 2.69235228 |
| 171 | spermatid development (GO:0007286) | 2.67849381 |
| 172 | protein maturation by protein folding (GO:0022417) | 2.66426737 |
| 173 | mitochondrial calcium ion transport (GO:0006851) | 2.66297420 |
| 174 | T cell selection (GO:0045058) | 2.66146175 |
| 175 | histone H4 deacetylation (GO:0070933) | 2.65944661 |
| 176 | positive regulation of interleukin-4 production (GO:0032753) | 2.64131409 |
| 177 | Peyers patch development (GO:0048541) | 2.63846407 |
| 178 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.63846407 |
| 179 | sexual reproduction (GO:0019953) | 2.62353866 |
| 180 | cellular response to interferon-beta (GO:0035458) | 2.62303215 |
| 181 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.60057976 |
| 182 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.59476553 |
| 183 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.57483960 |
| 184 | GDP-mannose metabolic process (GO:0019673) | 2.57413496 |
| 185 | dosage compensation (GO:0007549) | 2.57326379 |
| 186 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.56513508 |
| 187 | deoxyribose phosphate catabolic process (GO:0046386) | 2.56197013 |
| 188 | autophagic vacuole fusion (GO:0000046) | 2.55602799 |
| 189 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.55573824 |
| 190 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.54114535 |
| 191 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.53577617 |
| 192 | lysosome localization (GO:0032418) | 2.51201539 |
| 193 | positive regulation of T cell cytokine production (GO:0002726) | 2.50235893 |
| 194 | leukocyte aggregation (GO:0070486) | 2.49094945 |
| 195 | viral life cycle (GO:0019058) | 2.48914672 |
| 196 | negative regulation of phagocytosis (GO:0050765) | 2.48454059 |
| 197 | pentose-phosphate shunt (GO:0006098) | 2.48211210 |
| 198 | protein complex disassembly (GO:0043241) | 2.47434271 |
| 199 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.47209898 |
| 200 | positive regulation of odontogenesis (GO:0042482) | 2.45847285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.46885758 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.94004963 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.33583790 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.95147921 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.67761025 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.34301634 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.04454467 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.85782031 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.33863973 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.44895677 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.37317721 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.29378188 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.25827890 |
| 14 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.12131700 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.11397096 |
| 16 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.03933110 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.95371659 |
| 18 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.93428447 |
| 19 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.84560623 |
| 20 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.79901235 |
| 21 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.78591498 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.68435221 |
| 23 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.68155624 |
| 24 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.67821180 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67062540 |
| 26 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.65240801 |
| 27 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.58023525 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.56639635 |
| 29 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.53866519 |
| 30 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.53701850 |
| 31 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.53503619 |
| 32 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.52909473 |
| 33 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.51127644 |
| 34 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.50177962 |
| 35 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.49180961 |
| 36 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.48916723 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.48848903 |
| 38 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.48318552 |
| 39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.45047122 |
| 40 | MYB_26560356_Chip-Seq_TH2_Human | 1.44839031 |
| 41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.44656131 |
| 42 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43015175 |
| 43 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.41861840 |
| 44 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.41755283 |
| 45 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.41512585 |
| 46 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.41127136 |
| 47 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.40632018 |
| 48 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.39629123 |
| 49 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.37631604 |
| 50 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.37611227 |
| 51 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.36614933 |
| 52 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.36568574 |
| 53 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.34357047 |
| 54 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.31125496 |
| 55 | MYB_26560356_Chip-Seq_TH1_Human | 1.30201347 |
| 56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.29177532 |
| 57 | * P300_27268052_Chip-Seq_Bcells_Human | 1.29171096 |
| 58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.27788185 |
| 59 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.27592734 |
| 60 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.27313125 |
| 61 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.26021343 |
| 62 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.25652124 |
| 63 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25511894 |
| 64 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23997735 |
| 65 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.21163834 |
| 66 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.21158659 |
| 67 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.21115673 |
| 68 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.21043627 |
| 69 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20967610 |
| 70 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.18481813 |
| 71 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.18157540 |
| 72 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.17107298 |
| 73 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.16477369 |
| 74 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.16457003 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15845406 |
| 76 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.15355944 |
| 77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14662234 |
| 78 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.14502933 |
| 79 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.13826003 |
| 80 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13607220 |
| 81 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.13130084 |
| 82 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.13109923 |
| 83 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.12431548 |
| 84 | SPI1_23127762_ChIP-Seq_K562_Human | 1.11658846 |
| 85 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.11514785 |
| 86 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.10783683 |
| 87 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.10698721 |
| 88 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09908087 |
| 89 | SA1_27219007_Chip-Seq_Bcells_Human | 1.09841914 |
| 90 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.09458772 |
| 91 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.09130543 |
| 92 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.08972544 |
| 93 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.05670285 |
| 94 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.05314931 |
| 95 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.04230852 |
| 96 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.03072910 |
| 97 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01857761 |
| 98 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.01760754 |
| 99 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.01596254 |
| 100 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.98470402 |
| 101 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.97448644 |
| 102 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.96784976 |
| 103 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.96590888 |
| 104 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.95398318 |
| 105 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.94881759 |
| 106 | MYC_22102868_ChIP-Seq_BL_Human | 0.94293502 |
| 107 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.94171096 |
| 108 | MAF_26560356_Chip-Seq_TH1_Human | 0.93684193 |
| 109 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.93191379 |
| 110 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.92136383 |
| 111 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91248733 |
| 112 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90726384 |
| 113 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89524804 |
| 114 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88256077 |
| 115 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.88078160 |
| 116 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.86727881 |
| 117 | GATA1_19941826_ChIP-Seq_K562_Human | 0.86185835 |
| 118 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.85715489 |
| 119 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.84965905 |
| 120 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.83914164 |
| 121 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.83016502 |
| 122 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.82174855 |
| 123 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81926137 |
| 124 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.81467202 |
| 125 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.81234098 |
| 126 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.80883354 |
| 127 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.80612727 |
| 128 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.78263435 |
| 129 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.78231945 |
| 130 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.78064340 |
| 131 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77791728 |
| 132 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.77374393 |
| 133 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77324881 |
| 134 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.76849689 |
| 135 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.76152650 |
| 136 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.75536140 |
| 137 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.75309870 |
| 138 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.74620345 |
| 139 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.73892682 |
| 140 | MAF_26560356_Chip-Seq_TH2_Human | 0.73795722 |
| 141 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.73699949 |
| 142 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.73541478 |
| 143 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.73102012 |
| 144 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.72948391 |
| 145 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.72859173 |
| 146 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.72581061 |
| 147 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.72553438 |
| 148 | P68_20966046_ChIP-Seq_HELA_Human | 0.72477613 |
| 149 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.72008149 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.40858016 |
| 2 | MP0005360_urolithiasis | 5.74286580 |
| 3 | MP0005365_abnormal_bile_salt | 5.16460707 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.07941186 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.41232108 |
| 6 | MP0005410_abnormal_fertilization | 4.32536079 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 4.02685101 |
| 8 | MP0009840_abnormal_foam_cell | 3.34462917 |
| 9 | MP0003252_abnormal_bile_duct | 3.31540949 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.00287871 |
| 11 | MP0005083_abnormal_biliary_tract | 2.86586275 |
| 12 | MP0003763_abnormal_thymus_physiology | 2.79091704 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.52809211 |
| 14 | MP0003656_abnormal_erythrocyte_physiolo | 2.51838517 |
| 15 | MP0009278_abnormal_bone_marrow | 2.47979446 |
| 16 | MP0005332_abnormal_amino_acid | 2.37148931 |
| 17 | MP0009333_abnormal_splenocyte_physiolog | 2.26891020 |
| 18 | MP0000465_gastrointestinal_hemorrhage | 2.21645065 |
| 19 | MP0002398_abnormal_bone_marrow | 2.16144701 |
| 20 | MP0003195_calcinosis | 2.06758771 |
| 21 | MP0000609_abnormal_liver_physiology | 2.05149324 |
| 22 | MP0001666_abnormal_nutrient_absorption | 2.00425740 |
| 23 | MP0002420_abnormal_adaptive_immunity | 1.98622278 |
| 24 | MP0001819_abnormal_immune_cell | 1.96461189 |
| 25 | MP0003172_abnormal_lysosome_physiology | 1.95308119 |
| 26 | MP0005000_abnormal_immune_tolerance | 1.95293161 |
| 27 | MP0005319_abnormal_enzyme/_coenzyme | 1.94303521 |
| 28 | MP0003186_abnormal_redox_activity | 1.91647374 |
| 29 | MP0002722_abnormal_immune_system | 1.91429505 |
| 30 | MP0002723_abnormal_immune_serum | 1.89371528 |
| 31 | MP0003303_peritoneal_inflammation | 1.88423670 |
| 32 | MP0005671_abnormal_response_to | 1.84284091 |
| 33 | MP0000703_abnormal_thymus_morphology | 1.83816810 |
| 34 | MP0004019_abnormal_vitamin_homeostasis | 1.82437957 |
| 35 | MP0002118_abnormal_lipid_homeostasis | 1.81622249 |
| 36 | MP0001873_stomach_inflammation | 1.74503072 |
| 37 | MP0000716_abnormal_immune_system | 1.74292033 |
| 38 | MP0002452_abnormal_antigen_presenting | 1.70597314 |
| 39 | MP0002429_abnormal_blood_cell | 1.68254748 |
| 40 | MP0005670_abnormal_white_adipose | 1.62979088 |
| 41 | MP0004808_abnormal_hematopoietic_stem | 1.60028002 |
| 42 | MP0001764_abnormal_homeostasis | 1.59298762 |
| 43 | MP0008260_abnormal_autophagy | 1.58794634 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.58527112 |
| 45 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56909074 |
| 46 | MP0003866_abnormal_defecation | 1.55686410 |
| 47 | MP0009764_decreased_sensitivity_to | 1.53239790 |
| 48 | MP0003011_delayed_dark_adaptation | 1.52918134 |
| 49 | MP0002138_abnormal_hepatobiliary_system | 1.51024924 |
| 50 | MP0002148_abnormal_hypersensitivity_rea | 1.49615051 |
| 51 | MP0002405_respiratory_system_inflammati | 1.47192247 |
| 52 | MP0009643_abnormal_urine_homeostasis | 1.42777807 |
| 53 | MP0006036_abnormal_mitochondrial_physio | 1.40200583 |
| 54 | MP0000015_abnormal_ear_pigmentation | 1.37432423 |
| 55 | MP0000678_abnormal_parathyroid_gland | 1.31431576 |
| 56 | MP0001790_abnormal_immune_system | 1.28901537 |
| 57 | MP0005387_immune_system_phenotype | 1.28901537 |
| 58 | MP0002019_abnormal_tumor_incidence | 1.27689591 |
| 59 | MP0003698_abnormal_male_reproductive | 1.27374005 |
| 60 | MP0002132_abnormal_respiratory_system | 1.26684471 |
| 61 | MP0002254_reproductive_system_inflammat | 1.25688431 |
| 62 | MP0008469_abnormal_protein_level | 1.25641610 |
| 63 | MP0000598_abnormal_liver_morphology | 1.24569139 |
| 64 | MP0003868_abnormal_feces_composition | 1.24537265 |
| 65 | MP0005464_abnormal_platelet_physiology | 1.21565961 |
| 66 | MP0003436_decreased_susceptibility_to | 1.21116444 |
| 67 | MP0003724_increased_susceptibility_to | 1.20003454 |
| 68 | MP0001348_abnormal_lacrimal_gland | 1.19318616 |
| 69 | MP0005636_abnormal_mineral_homeostasis | 1.19098805 |
| 70 | MP0005377_hearing/vestibular/ear_phenot | 1.17162944 |
| 71 | MP0003878_abnormal_ear_physiology | 1.17162944 |
| 72 | MP0009763_increased_sensitivity_to | 1.12009711 |
| 73 | MP0005451_abnormal_body_composition | 1.11965749 |
| 74 | MP0001929_abnormal_gametogenesis | 1.11865431 |
| 75 | MP0001533_abnormal_skeleton_physiology | 1.10697900 |
| 76 | MP0000685_abnormal_immune_system | 1.09687015 |
| 77 | MP0005397_hematopoietic_system_phenotyp | 1.08279132 |
| 78 | MP0001545_abnormal_hematopoietic_system | 1.08279132 |
| 79 | MP0009697_abnormal_copulation | 1.07756808 |
| 80 | MP0004147_increased_porphyrin_level | 1.06590587 |
| 81 | MP0005408_hypopigmentation | 1.04725622 |
| 82 | MP0001835_abnormal_antigen_presentation | 1.00194902 |
| 83 | MP0005375_adipose_tissue_phenotype | 1.00002907 |
| 84 | MP0000681_abnormal_thyroid_gland | 0.98987504 |
| 85 | MP0009785_altered_susceptibility_to | 0.98890140 |
| 86 | MP0001853_heart_inflammation | 0.97559242 |
| 87 | MP0010368_abnormal_lymphatic_system | 0.93152368 |
| 88 | MP0004130_abnormal_muscle_cell | 0.91272818 |
| 89 | MP0005647_abnormal_sex_gland | 0.90160513 |
| 90 | MP0009642_abnormal_blood_homeostasis | 0.89795969 |
| 91 | MP0000313_abnormal_cell_death | 0.89363927 |
| 92 | MP0002396_abnormal_hematopoietic_system | 0.86212012 |
| 93 | MP0008874_decreased_physiological_sensi | 0.86122170 |
| 94 | MP0000858_altered_metastatic_potential | 0.85487306 |
| 95 | MP0003705_abnormal_hypodermis_morpholog | 0.84837001 |
| 96 | MP0002166_altered_tumor_susceptibility | 0.84355583 |
| 97 | MP0005025_abnormal_response_to | 0.82008754 |
| 98 | MP0005075_abnormal_melanosome_morpholog | 0.81862125 |
| 99 | MP0002822_catalepsy | 0.81839771 |
| 100 | MP0002060_abnormal_skin_morphology | 0.81641885 |
| 101 | MP0009765_abnormal_xenobiotic_induced | 0.79463528 |
| 102 | MP0004233_abnormal_muscle_weight | 0.78845545 |
| 103 | MP0000003_abnormal_adipose_tissue | 0.78689055 |
| 104 | MP0005376_homeostasis/metabolism_phenot | 0.77838558 |
| 105 | MP0005266_abnormal_metabolism | 0.77269450 |
| 106 | MP0002933_joint_inflammation | 0.76535584 |
| 107 | MP0008007_abnormal_cellular_replicative | 0.76471496 |
| 108 | MP0001765_abnormal_ion_homeostasis | 0.75676929 |
| 109 | MP0005334_abnormal_fat_pad | 0.74339938 |
| 110 | MP0006035_abnormal_mitochondrial_morpho | 0.73303026 |
| 111 | MP0004381_abnormal_hair_follicle | 0.72937949 |
| 112 | MP0002161_abnormal_fertility/fecundity | 0.71363545 |
| 113 | MP0005058_abnormal_lysosome_morphology | 0.71053915 |
| 114 | MP0001845_abnormal_inflammatory_respons | 0.71020132 |
| 115 | MP0001756_abnormal_urination | 0.70423371 |
| 116 | MP0006054_spinal_hemorrhage | 0.70377911 |
| 117 | MP0004947_skin_inflammation | 0.70324852 |
| 118 | MP0002419_abnormal_innate_immunity | 0.69546511 |
| 119 | MP0002136_abnormal_kidney_physiology | 0.68943328 |
| 120 | MP0005166_decreased_susceptibility_to | 0.68701507 |
| 121 | MP0005535_abnormal_body_temperature | 0.68211019 |
| 122 | MP0003786_premature_aging | 0.67698892 |
| 123 | MP0004782_abnormal_surfactant_physiolog | 0.66719713 |
| 124 | MP0001986_abnormal_taste_sensitivity | 0.66599412 |
| 125 | MP0002837_dystrophic_cardiac_calcinosis | 0.66209991 |
| 126 | MP0005220_abnormal_exocrine_pancreas | 0.65601314 |
| 127 | MP0000490_abnormal_crypts_of | 0.64870921 |
| 128 | MP0005084_abnormal_gallbladder_morpholo | 0.64138020 |
| 129 | MP0000343_altered_response_to | 0.63758177 |
| 130 | MP0009379_abnormal_foot_pigmentation | 0.62954152 |
| 131 | MP0005023_abnormal_wound_healing | 0.62862749 |
| 132 | MP0002078_abnormal_glucose_homeostasis | 0.62567418 |
| 133 | MP0000372_irregular_coat_pigmentation | 0.62045518 |
| 134 | MP0005666_abnormal_adipose_tissue | 0.61778320 |
| 135 | MP0002971_abnormal_brown_adipose | 0.61362362 |
| 136 | MP0004185_abnormal_adipocyte_glucose | 0.61244594 |
| 137 | MP0000358_abnormal_cell_content/ | 0.60707262 |
| 138 | MP0003075_altered_response_to | 0.60026408 |
| 139 | MP0005174_abnormal_tail_pigmentation | 0.59773720 |
| 140 | MP0001663_abnormal_digestive_system | 0.59218270 |
| 141 | MP0009115_abnormal_fat_cell | 0.56989841 |
| 142 | MP0010155_abnormal_intestine_physiology | 0.56539378 |
| 143 | MP0009931_abnormal_skin_appearance | 0.55942356 |
| 144 | MP0006082_CNS_inflammation | 0.54912560 |
| 145 | MP0002098_abnormal_vibrissa_morphology | 0.54353926 |
| 146 | MP0002796_impaired_skin_barrier | 0.52543182 |
| 147 | MP0000689_abnormal_spleen_morphology | 0.50166497 |
| 148 | MP0002928_abnormal_bile_duct | 0.49984931 |
| 149 | MP0008873_increased_physiological_sensi | 0.49917735 |
| 150 | MP0003453_abnormal_keratinocyte_physiol | 0.49838271 |
| 151 | MP0002970_abnormal_white_adipose | 0.49121527 |
| 152 | MP0003638_abnormal_response/metabolism_ | 0.48856581 |
| 153 | MP0001800_abnormal_humoral_immune | 0.47902234 |
| 154 | MP0002877_abnormal_melanocyte_morpholog | 0.47386938 |
| 155 | MP0000249_abnormal_blood_vessel | 0.46135462 |
| 156 | MP0000604_amyloidosis | 0.45764676 |
| 157 | MP0000371_diluted_coat_color | 0.45087469 |
| 158 | MP0002135_abnormal_kidney_morphology | 0.44243450 |
| 159 | MP0001243_abnormal_dermal_layer | 0.44024581 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.39269366 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.63549977 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.41086272 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.33733039 |
| 5 | Xanthomatosis (HP:0000991) | 5.11666681 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.02042236 |
| 7 | Hyperlipoproteinemia (HP:0010980) | 4.55059270 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 4.52828827 |
| 9 | Severe visual impairment (HP:0001141) | 4.50064273 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.42143167 |
| 11 | Complement deficiency (HP:0004431) | 4.28194150 |
| 12 | Hyperammonemia (HP:0001987) | 4.15355083 |
| 13 | Seborrheic dermatitis (HP:0001051) | 4.09685509 |
| 14 | Hypertensive crisis (HP:0100735) | 4.08505553 |
| 15 | Thrombocytosis (HP:0001894) | 4.06223453 |
| 16 | Petechiae (HP:0000967) | 4.02324292 |
| 17 | Obstructive lung disease (HP:0006536) | 4.01518321 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 4.01518321 |
| 19 | Ketosis (HP:0001946) | 4.01123953 |
| 20 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.90083317 |
| 21 | Joint hemorrhage (HP:0005261) | 3.85786592 |
| 22 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.81174058 |
| 23 | Hyperglycinuria (HP:0003108) | 3.68551082 |
| 24 | Hypolipoproteinemia (HP:0010981) | 3.59654426 |
| 25 | Hyperbilirubinemia (HP:0002904) | 3.54155272 |
| 26 | Hypoglycemic coma (HP:0001325) | 3.48277789 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.47649016 |
| 28 | Hypoalphalipoproteinemia (HP:0003233) | 3.42083156 |
| 29 | Abnormality of the common coagulation pathway (HP:0010990) | 3.41647573 |
| 30 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.39290255 |
| 31 | Hyperglycinemia (HP:0002154) | 3.36887763 |
| 32 | Abnormality of complement system (HP:0005339) | 3.34290819 |
| 33 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.33851496 |
| 34 | Abnormality of glycine metabolism (HP:0010895) | 3.33473038 |
| 35 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.33473038 |
| 36 | Abnormality of methionine metabolism (HP:0010901) | 3.28625230 |
| 37 | Hypercholesterolemia (HP:0003124) | 3.24496364 |
| 38 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.23895991 |
| 39 | Fat malabsorption (HP:0002630) | 3.22179034 |
| 40 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.21058199 |
| 41 | Hyperthyroidism (HP:0000836) | 3.21027604 |
| 42 | Epidermoid cyst (HP:0200040) | 3.21023201 |
| 43 | Abnormality of the intrinsic pathway (HP:0010989) | 3.19297601 |
| 44 | Rhabdomyolysis (HP:0003201) | 3.14292775 |
| 45 | Fatigue (HP:0012378) | 3.10490905 |
| 46 | Abnormality of T cell physiology (HP:0011840) | 3.05255875 |
| 47 | Ketoacidosis (HP:0001993) | 2.98934820 |
| 48 | Dicarboxylic aciduria (HP:0003215) | 2.98892203 |
| 49 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.98892203 |
| 50 | Ragged-red muscle fibers (HP:0003200) | 2.98282015 |
| 51 | Truncus arteriosus (HP:0001660) | 2.95589779 |
| 52 | Myositis (HP:0100614) | 2.91794724 |
| 53 | Cerebral palsy (HP:0100021) | 2.91204008 |
| 54 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.90845768 |
| 55 | Generalized aminoaciduria (HP:0002909) | 2.87307922 |
| 56 | Panhypogammaglobulinemia (HP:0003139) | 2.85015657 |
| 57 | Systemic lupus erythematosus (HP:0002725) | 2.80413567 |
| 58 | Delayed CNS myelination (HP:0002188) | 2.77454082 |
| 59 | Abnormality of nucleobase metabolism (HP:0010932) | 2.77149567 |
| 60 | Metabolic acidosis (HP:0001942) | 2.69937713 |
| 61 | Renal Fanconi syndrome (HP:0001994) | 2.69283572 |
| 62 | Agammaglobulinemia (HP:0004432) | 2.68123907 |
| 63 | Granulocytopenia (HP:0001913) | 2.65552509 |
| 64 | Steatorrhea (HP:0002570) | 2.64880709 |
| 65 | Myocardial infarction (HP:0001658) | 2.63663253 |
| 66 | Increased intramyocellular lipid droplets (HP:0012240) | 2.60643332 |
| 67 | Muscle fiber atrophy (HP:0100295) | 2.60457788 |
| 68 | Hepatocellular carcinoma (HP:0001402) | 2.60189871 |
| 69 | Chest pain (HP:0100749) | 2.58985381 |
| 70 | Abnormal number of erythroid precursors (HP:0012131) | 2.55308390 |
| 71 | Abnormality of purine metabolism (HP:0004352) | 2.55195251 |
| 72 | Amyloidosis (HP:0011034) | 2.54949289 |
| 73 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.54132872 |
| 74 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.52528006 |
| 75 | Lethargy (HP:0001254) | 2.52120970 |
| 76 | Abnormality of reticulocytes (HP:0004312) | 2.48935738 |
| 77 | Gastrointestinal inflammation (HP:0004386) | 2.48491488 |
| 78 | Abnormality of serum amino acid levels (HP:0003112) | 2.47833339 |
| 79 | Poikilocytosis (HP:0004447) | 2.46975755 |
| 80 | Increased serum ferritin (HP:0003281) | 2.44247256 |
| 81 | Abnormality of iron homeostasis (HP:0011031) | 2.43972612 |
| 82 | Cholelithiasis (HP:0001081) | 2.43607076 |
| 83 | Atelectasis (HP:0100750) | 2.42213630 |
| 84 | Gingival bleeding (HP:0000225) | 2.41646740 |
| 85 | Abnormality of T cells (HP:0002843) | 2.41180427 |
| 86 | Abnormal gallbladder morphology (HP:0012437) | 2.35774552 |
| 87 | Spontaneous abortion (HP:0005268) | 2.34962171 |
| 88 | Abnormal gallbladder physiology (HP:0012438) | 2.34950296 |
| 89 | Cholecystitis (HP:0001082) | 2.34950296 |
| 90 | Myopathic facies (HP:0002058) | 2.34382230 |
| 91 | Gout (HP:0001997) | 2.34086861 |
| 92 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.33482411 |
| 93 | Brushfield spots (HP:0001088) | 2.33139738 |
| 94 | Tubulointerstitial nephritis (HP:0001970) | 2.32916185 |
| 95 | Menorrhagia (HP:0000132) | 2.32709955 |
| 96 | Meningitis (HP:0001287) | 2.30922248 |
| 97 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.30854298 |
| 98 | Cerebral edema (HP:0002181) | 2.30691615 |
| 99 | Spastic paraparesis (HP:0002313) | 2.30354461 |
| 100 | Progressive muscle weakness (HP:0003323) | 2.29579941 |
| 101 | Increased IgM level (HP:0003496) | 2.29523715 |
| 102 | Conjugated hyperbilirubinemia (HP:0002908) | 2.29066632 |
| 103 | Hepatosplenomegaly (HP:0001433) | 2.27742578 |
| 104 | Aplastic anemia (HP:0001915) | 2.27120401 |
| 105 | Polycythemia (HP:0001901) | 2.26325473 |
| 106 | Late onset (HP:0003584) | 2.25738722 |
| 107 | Cellulitis (HP:0100658) | 2.24219242 |
| 108 | Epistaxis (HP:0000421) | 2.22752045 |
| 109 | Hypertriglyceridemia (HP:0002155) | 2.21002524 |
| 110 | Malnutrition (HP:0004395) | 2.20802782 |
| 111 | Stomatitis (HP:0010280) | 2.20011029 |
| 112 | Acanthocytosis (HP:0001927) | 2.19906683 |
| 113 | Vomiting (HP:0002013) | 2.19870537 |
| 114 | Spastic diplegia (HP:0001264) | 2.19622596 |
| 115 | Inflammation of the large intestine (HP:0002037) | 2.19408111 |
| 116 | Asymmetric septal hypertrophy (HP:0001670) | 2.18953826 |
| 117 | Recurrent abscess formation (HP:0002722) | 2.18040878 |
| 118 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.17967459 |
| 119 | Reticulocytosis (HP:0001923) | 2.17891054 |
| 120 | Ileus (HP:0002595) | 2.16629427 |
| 121 | Nausea (HP:0002018) | 2.16415070 |
| 122 | Hepatic necrosis (HP:0002605) | 2.15875651 |
| 123 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.14123866 |
| 124 | Easy fatigability (HP:0003388) | 2.12681801 |
| 125 | Opisthotonus (HP:0002179) | 2.12105729 |
| 126 | Glomerulonephritis (HP:0000099) | 2.11750833 |
| 127 | Attenuation of retinal blood vessels (HP:0007843) | 2.11381638 |
| 128 | Vascular calcification (HP:0004934) | 2.10938387 |
| 129 | Pustule (HP:0200039) | 2.10514853 |
| 130 | Pulmonary fibrosis (HP:0002206) | 2.08944251 |
| 131 | Recurrent fungal infections (HP:0002841) | 2.08893125 |
| 132 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.06424809 |
| 133 | Neonatal onset (HP:0003623) | 2.06141814 |
| 134 | Reduced antithrombin III activity (HP:0001976) | 2.04964292 |
| 135 | Abnormality of the prostate (HP:0008775) | 2.04911461 |
| 136 | Prolonged neonatal jaundice (HP:0006579) | 2.03977414 |
| 137 | Mitral stenosis (HP:0001718) | 2.03566470 |
| 138 | Slow saccadic eye movements (HP:0000514) | 2.02830605 |
| 139 | Elevated hepatic transaminases (HP:0002910) | 2.02653290 |
| 140 | Hypoparathyroidism (HP:0000829) | 2.02640697 |
| 141 | Esophageal varix (HP:0002040) | 2.02616097 |
| 142 | Thrombophlebitis (HP:0004418) | 2.02009006 |
| 143 | Exercise-induced myalgia (HP:0003738) | 2.01894840 |
| 144 | Gastrointestinal infarctions (HP:0005244) | 2.01834698 |
| 145 | Pallor (HP:0000980) | 2.01000607 |
| 146 | Prolonged bleeding time (HP:0003010) | 2.00851642 |
| 147 | Hepatocellular necrosis (HP:0001404) | 2.00477504 |
| 148 | Abnormality of the gallbladder (HP:0005264) | 1.99384006 |
| 149 | Pancreatitis (HP:0001733) | 1.99372320 |
| 150 | Type 2 muscle fiber atrophy (HP:0003554) | 1.99337234 |
| 151 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 1.99136972 |
| 152 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.97526760 |
| 153 | Hemorrhage of the eye (HP:0011885) | 1.97401197 |
| 154 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.94756828 |
| 155 | Vasculitis (HP:0002633) | 1.92399677 |
| 156 | Hypochromic microcytic anemia (HP:0004840) | 1.91982068 |
| 157 | Hypochromic anemia (HP:0001931) | 1.91129040 |
| 158 | Skin nodule (HP:0200036) | 1.90251410 |
| 159 | Paralysis (HP:0003470) | 1.88485408 |
| 160 | Myoglobinuria (HP:0002913) | 1.87492493 |
| 161 | Abnormal platelet function (HP:0011869) | 1.87400474 |
| 162 | Impaired platelet aggregation (HP:0003540) | 1.87400474 |
| 163 | Increased muscle lipid content (HP:0009058) | 1.87132120 |
| 164 | Progressive microcephaly (HP:0000253) | 1.87052430 |
| 165 | Acute lymphatic leukemia (HP:0006721) | 1.87035440 |
| 166 | Muscle stiffness (HP:0003552) | 1.86456487 |
| 167 | Acute hepatic failure (HP:0006554) | 1.86046610 |
| 168 | Severe combined immunodeficiency (HP:0004430) | 1.85895649 |
| 169 | Cardiovascular calcification (HP:0011915) | 1.85086280 |
| 170 | Irritability (HP:0000737) | 1.84842312 |
| 171 | Hypergonadotropic hypogonadism (HP:0000815) | 1.83909589 |
| 172 | Purpura (HP:0000979) | 1.83468949 |
| 173 | Growth hormone excess (HP:0000845) | 1.81820221 |
| 174 | Recurrent viral infections (HP:0004429) | 1.81371237 |
| 175 | Hypoglycemic seizures (HP:0002173) | 1.81196504 |
| 176 | Abnormality of B cell number (HP:0010975) | 1.80351360 |
| 177 | Eczematoid dermatitis (HP:0000976) | 1.79585466 |
| 178 | Microvesicular hepatic steatosis (HP:0001414) | 1.77472099 |
| 179 | Hypergammaglobulinemia (HP:0010702) | 1.77100788 |
| 180 | Abnormality of the tricuspid valve (HP:0001702) | 1.76836600 |
| 181 | Joint swelling (HP:0001386) | 1.76319814 |
| 182 | Thoracic kyphosis (HP:0002942) | 1.76006537 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.17113465 |
| 2 | ERN1 | 5.10158134 |
| 3 | TESK2 | 4.03128404 |
| 4 | SIK1 | 2.70355874 |
| 5 | CDK19 | 2.65139317 |
| 6 | FGFR4 | 2.42709148 |
| 7 | TRIB3 | 2.39198666 |
| 8 | FLT3 | 2.34377516 |
| 9 | TNK2 | 2.23517324 |
| 10 | MAP3K10 | 2.19442805 |
| 11 | TXK | 2.17837188 |
| 12 | FES | 2.15678542 |
| 13 | TYK2 | 2.07421704 |
| 14 | VRK2 | 2.06160048 |
| 15 | MAP2K3 | 2.05546158 |
| 16 | TBK1 | 1.94679968 |
| 17 | NME2 | 1.91376604 |
| 18 | RIPK4 | 1.89783490 |
| 19 | STK16 | 1.88987302 |
| 20 | MAP3K3 | 1.87327208 |
| 21 | KIT | 1.85116812 |
| 22 | PIM2 | 1.84985306 |
| 23 | TAOK3 | 1.82677934 |
| 24 | TGFBR2 | 1.81129226 |
| 25 | KDR | 1.72246529 |
| 26 | MST1R | 1.67210642 |
| 27 | PKN2 | 1.66538720 |
| 28 | INSRR | 1.58995353 |
| 29 | MAP4K2 | 1.58802371 |
| 30 | SIK2 | 1.50412155 |
| 31 | MAPK11 | 1.50302106 |
| 32 | MAPKAPK3 | 1.45971195 |
| 33 | MAP3K13 | 1.43251527 |
| 34 | MAP4K1 | 1.41829323 |
| 35 | IRAK3 | 1.41484839 |
| 36 | ARAF | 1.40634465 |
| 37 | BTK | 1.36920768 |
| 38 | PRPF4B | 1.30928235 |
| 39 | PLK4 | 1.23716537 |
| 40 | PRKD3 | 1.23598221 |
| 41 | MAP3K11 | 1.21927164 |
| 42 | IKBKE | 1.21850714 |
| 43 | CDK12 | 1.16883528 |
| 44 | EEF2K | 1.15509591 |
| 45 | MYLK | 1.12822596 |
| 46 | PASK | 1.11599369 |
| 47 | LMTK2 | 1.10284852 |
| 48 | ABL2 | 1.10041316 |
| 49 | EPHA3 | 1.08163064 |
| 50 | IKBKB | 1.04971754 |
| 51 | TIE1 | 1.03979054 |
| 52 | SMG1 | 1.00796117 |
| 53 | ZAP70 | 0.97100850 |
| 54 | CSF1R | 0.94107025 |
| 55 | TEC | 0.93892972 |
| 56 | MAPK4 | 0.92955121 |
| 57 | LRRK2 | 0.92620123 |
| 58 | PDPK1 | 0.92292606 |
| 59 | NEK9 | 0.92078563 |
| 60 | MAP3K1 | 0.91746265 |
| 61 | HCK | 0.91721647 |
| 62 | DYRK1B | 0.91236676 |
| 63 | RPS6KB2 | 0.90657248 |
| 64 | PDK1 | 0.90440083 |
| 65 | ICK | 0.89269841 |
| 66 | JAK2 | 0.89098094 |
| 67 | STK38 | 0.88355782 |
| 68 | MAP2K6 | 0.86432942 |
| 69 | MARK2 | 0.86315035 |
| 70 | PIK3CG | 0.85209024 |
| 71 | JAK3 | 0.83721747 |
| 72 | LCK | 0.81476814 |
| 73 | MAP3K14 | 0.80133839 |
| 74 | MAP3K7 | 0.79815352 |
| 75 | TGFBR1 | 0.78673052 |
| 76 | PRKD2 | 0.78630070 |
| 77 | MAPK12 | 0.78567963 |
| 78 | TESK1 | 0.76705884 |
| 79 | MATK | 0.76384613 |
| 80 | PDK4 | 0.76084833 |
| 81 | PDK3 | 0.76084833 |
| 82 | BMX | 0.74209173 |
| 83 | STK4 | 0.72020736 |
| 84 | TTN | 0.71560979 |
| 85 | PTK6 | 0.71505856 |
| 86 | SCYL2 | 0.69559183 |
| 87 | PINK1 | 0.69357738 |
| 88 | MAP3K6 | 0.66574019 |
| 89 | MAPK15 | 0.65938994 |
| 90 | GRK6 | 0.62548825 |
| 91 | PRKAA2 | 0.62254842 |
| 92 | CDK4 | 0.61250958 |
| 93 | PRKCQ | 0.61035210 |
| 94 | JAK1 | 0.60996482 |
| 95 | CDK6 | 0.59948483 |
| 96 | HIPK2 | 0.59660166 |
| 97 | PIM1 | 0.58335657 |
| 98 | SYK | 0.58273758 |
| 99 | ERBB2 | 0.58105381 |
| 100 | RPS6KA2 | 0.56275248 |
| 101 | PAK4 | 0.55536712 |
| 102 | CAMKK1 | 0.54938253 |
| 103 | NLK | 0.54463672 |
| 104 | RIPK1 | 0.52847519 |
| 105 | CSK | 0.52512277 |
| 106 | MARK3 | 0.51146770 |
| 107 | CHUK | 0.51093786 |
| 108 | MAP3K8 | 0.50236715 |
| 109 | IRAK4 | 0.49996931 |
| 110 | STK10 | 0.48627352 |
| 111 | SIK3 | 0.48114725 |
| 112 | DYRK3 | 0.48061350 |
| 113 | ILK | 0.47562542 |
| 114 | RPS6KA6 | 0.47533411 |
| 115 | TRPM7 | 0.45544333 |
| 116 | RPS6KL1 | 0.44938330 |
| 117 | RPS6KC1 | 0.44938330 |
| 118 | MAP2K4 | 0.44712560 |
| 119 | BRD4 | 0.43671887 |
| 120 | RPS6KA4 | 0.43313029 |
| 121 | MAP2K2 | 0.42949207 |
| 122 | TAOK2 | 0.42897657 |
| 123 | DAPK1 | 0.41916617 |
| 124 | DDR2 | 0.41550401 |
| 125 | CDK9 | 0.40742373 |
| 126 | MUSK | 0.40498155 |
| 127 | CCNB1 | 0.40360771 |
| 128 | LYN | 0.39191192 |
| 129 | EPHB2 | 0.37885766 |
| 130 | ERBB4 | 0.37418628 |
| 131 | PRKG2 | 0.36797730 |
| 132 | MTOR | 0.36659566 |
| 133 | CDK7 | 0.35481720 |
| 134 | RPS6KA1 | 0.35174574 |
| 135 | BLK | 0.35157123 |
| 136 | AURKA | 0.35021073 |
| 137 | ATR | 0.34548777 |
| 138 | MAPK3 | 0.34267036 |
| 139 | GRK7 | 0.32896989 |
| 140 | VRK1 | 0.32639965 |
| 141 | PRKCD | 0.31899414 |
| 142 | ACVR1B | 0.31437626 |
| 143 | PRKACG | 0.29870384 |
| 144 | WEE1 | 0.28231482 |
| 145 | ITK | 0.28151886 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.94202354 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.62536023 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.15609152 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.92659529 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.66066348 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.56475326 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.44922754 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.42079144 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.41491271 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.40204172 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.30769987 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.29061784 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.18155567 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.13681900 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.10378434 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 2.03402602 |
| 17 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.02003414 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.99219464 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.97022747 |
| 20 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.96316513 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.95393360 |
| 22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.94885255 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93689236 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.86723946 |
| 25 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.86438239 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.85893282 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85219916 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.85164489 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.83538414 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.83518314 |
| 31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.82287127 |
| 32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.81562112 |
| 33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.80108338 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.75892665 |
| 35 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.72902487 |
| 36 | Sulfur relay system_Homo sapiens_hsa04122 | 1.71046992 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.67332942 |
| 38 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.67325016 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.66923374 |
| 40 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.66385456 |
| 41 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.63652303 |
| 42 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.61987612 |
| 43 | Retinol metabolism_Homo sapiens_hsa00830 | 1.59326520 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.57587839 |
| 45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56255008 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.55765732 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55410901 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.49028479 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.45718592 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.41180293 |
| 51 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.40397607 |
| 52 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.39692907 |
| 53 | Carbon metabolism_Homo sapiens_hsa01200 | 1.34394244 |
| 54 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.33624936 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.32789157 |
| 56 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.31834861 |
| 57 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.29837086 |
| 58 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.28443190 |
| 59 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.26744064 |
| 60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.25867999 |
| 61 | Measles_Homo sapiens_hsa05162 | 1.23561020 |
| 62 | Viral myocarditis_Homo sapiens_hsa05416 | 1.21084055 |
| 63 | ABC transporters_Homo sapiens_hsa02010 | 1.19457368 |
| 64 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.19084945 |
| 65 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.16987695 |
| 66 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.16826497 |
| 67 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.16564405 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.14829680 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 1.13436764 |
| 70 | Bile secretion_Homo sapiens_hsa04976 | 1.12854923 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.07630711 |
| 72 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.06914318 |
| 73 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.05049891 |
| 74 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.04457687 |
| 75 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.02494578 |
| 76 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.00560280 |
| 77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.98426723 |
| 78 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.97701153 |
| 79 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.97268136 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.97256797 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97099651 |
| 82 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.94932496 |
| 83 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.94013188 |
| 84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93759608 |
| 85 | Asthma_Homo sapiens_hsa05310 | 0.90279543 |
| 86 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.90067545 |
| 87 | Purine metabolism_Homo sapiens_hsa00230 | 0.89810140 |
| 88 | Influenza A_Homo sapiens_hsa05164 | 0.89655440 |
| 89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.89030919 |
| 90 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.88579365 |
| 91 | Shigellosis_Homo sapiens_hsa05131 | 0.82532985 |
| 92 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.82486362 |
| 93 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.80939171 |
| 94 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.76327408 |
| 95 | Spliceosome_Homo sapiens_hsa03040 | 0.75306070 |
| 96 | Lysine degradation_Homo sapiens_hsa00310 | 0.75206158 |
| 97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.74857261 |
| 98 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.73962059 |
| 99 | RNA transport_Homo sapiens_hsa03013 | 0.73125785 |
| 100 | Hepatitis B_Homo sapiens_hsa05161 | 0.72945775 |
| 101 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71259891 |
| 102 | Galactose metabolism_Homo sapiens_hsa00052 | 0.70612417 |
| 103 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.69407319 |
| 104 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.69357999 |
| 105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.65090677 |
| 106 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64168249 |
| 107 | RNA polymerase_Homo sapiens_hsa03020 | 0.63874185 |
| 108 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.63593093 |
| 109 | Mismatch repair_Homo sapiens_hsa03430 | 0.61956328 |
| 110 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.59868648 |
| 111 | Tuberculosis_Homo sapiens_hsa05152 | 0.58487765 |
| 112 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.58388933 |
| 113 | Apoptosis_Homo sapiens_hsa04210 | 0.57364285 |
| 114 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.57011760 |
| 115 | Metabolic pathways_Homo sapiens_hsa01100 | 0.56643779 |
| 116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55008471 |
| 117 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.53478920 |
| 118 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.53026085 |
| 119 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52670723 |
| 120 | Parkinsons disease_Homo sapiens_hsa05012 | 0.50252802 |
| 121 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.49529736 |
| 122 | Homologous recombination_Homo sapiens_hsa03440 | 0.46744183 |
| 123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42426170 |
| 124 | Ribosome_Homo sapiens_hsa03010 | 0.42010793 |
| 125 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41171342 |
| 126 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40771922 |
| 127 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.40057601 |
| 128 | Olfactory transduction_Homo sapiens_hsa04740 | 0.39801726 |
| 129 | Hepatitis C_Homo sapiens_hsa05160 | 0.38169320 |
| 130 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.37308460 |
| 131 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.36752546 |
| 132 | Huntingtons disease_Homo sapiens_hsa05016 | 0.35588012 |
| 133 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.34454886 |
| 134 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33881087 |
| 135 | Bladder cancer_Homo sapiens_hsa05219 | 0.32973414 |
| 136 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.32223364 |
| 137 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.31205380 |
| 138 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.29769333 |
| 139 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.28140962 |
| 140 | Insulin resistance_Homo sapiens_hsa04931 | 0.27665816 |
| 141 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26528720 |
| 142 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.22014122 |
| 143 | DNA replication_Homo sapiens_hsa03030 | 0.21769196 |
| 144 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.20734381 |
| 145 | Other glycan degradation_Homo sapiens_hsa00511 | 0.20158764 |
| 146 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.17384412 |
| 147 | Legionellosis_Homo sapiens_hsa05134 | 0.16893132 |
| 148 | Prion diseases_Homo sapiens_hsa05020 | 0.14209254 |
| 149 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.11710947 |
| 150 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.11373185 |
| 151 | Base excision repair_Homo sapiens_hsa03410 | 0.03750402 |
| 152 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01597420 |
| 153 | Leishmaniasis_Homo sapiens_hsa05140 | 0.01408288 |
| 154 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.00688009 |
| 155 | Herpes simplex infection_Homo sapiens_hsa05168 | -0.0484916 |
| 156 | Malaria_Homo sapiens_hsa05144 | -0.0481972 |
| 157 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | -0.0460422 |
| 158 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0288821 |
| 159 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0288531 |
| 160 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0285302 |
| 161 | Lysosome_Homo sapiens_hsa04142 | -0.0267890 |
| 162 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | -0.0085373 |
| 163 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.0063764 |

